Viatris (VTRS) Research & Development (2020 - 2026)

Viatris (VTRS) recorded quarterly Research & Development of $248.6 million in Q1 2026, down 9.5% quarter-over-quarter from $274.7 million in Q4 2025, and up 11.98% on a YoY basis from $222.0 million in Q1 2025.

Viatris (VTRS) Research & Development (2020 - 2026) Analysis & Trends

Viatris' Research & Development history runs 7 years deep, the most recent figure standing at $248.6 million for Q1 2026.

  • In Q1 2026, Research & Development rose 11.98% year-over-year to $248.6 million; the TTM figure through Mar 2026 stood at $992.5 million (up 19.43% YoY), while the FY2025 annual figure was $965.9 million, up 19.44% from the prior year.
  • Research & Development was $248.6 million for Q1 2026 at Viatris, down from $274.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $274.7 million in Q4 2025 to a low of $142.3 million in Q1 2022.
  • Historically, Research & Development has averaged $205.3 million across 5 years, with a median of $204.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Research & Development dropped 22.71% in 2022, then jumped 33.03% in 2025.
  • A 5-year view of Research & Development shows it stood at $182.4 million in 2022, then rose by 11.18% to $202.8 million in 2023, then climbed by 1.82% to $206.5 million in 2024, then surged by 33.03% to $274.7 million in 2025, then slipped by 9.5% to $248.6 million in 2026.
  • The last three Research & Development figures came in at $248.6 million (Q1 2026), $274.7 million (Q4 2025), and $250.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Viatris - - 1.16 Bn 248.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 248.60 Mn
Dec 31, 2025 274.70 Mn
Sep 30, 2025 250.40 Mn
Jun 30, 2025 218.80 Mn
Mar 31, 2025 222.00 Mn
Dec 31, 2024 206.50 Mn
Sep 30, 2024 198.40 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 199.70 Mn
Dec 31, 2023 202.80 Mn
Sep 30, 2023 211.20 Mn
Jun 30, 2023 208.30 Mn
Mar 31, 2023 182.90 Mn
Dec 31, 2022 182.40 Mn
Sep 30, 2022 174.90 Mn
Jun 30, 2022 162.60 Mn
Mar 31, 2022 142.30 Mn
Dec 31, 2021 197.10 Mn
Sep 30, 2021 152.10 Mn
Jun 30, 2021 147.70 Mn